Small Cap
Medical Instruments & Supplies
Stocks Ranked by
Market Capitalization
| # | Name | Market cap | Price |
Price change % |
|
|---|---|---|---|---|---|
| 1 |
1
LeMaitre Vascular
LMAT
$1.85B
| $1.85B | $80.69 | 1.32% |
|
| 2 |
2
Dentsply Sirona
XRAY
$1.76B
| $1.76B | $8.83 | 1.61% |
|
| 3 |
3
Azenta
AZTA
$1.65B
| $1.65B | $37.72 | 4.78% |
|
| 4 |
4
Kestra Medical Technologies
KMTS
$1.61B
| $1.61B | $26.98 | 4.7% |
|
| 5 |
5
STAAR Surgical
STAA
$1.09B
| $1.09B | $21.67 | 3.17% |
|
| 6 |
6
AngioDynamics
ANGO
$484M
| $484M | $11.52 | 2.58% |
|
| 7 |
7
Sanara MedTech
SMTI
$322M
| $322M | $35.07 | 0.06% |
|
| 8 |
8
Embecta
EMBC
$322M
| $322M | $5.68 | 1.22% |
|
| 9 |
9
Perspective Therapeutics
CATX
$304M
| $304M | $2.66 | 1.85% |
|
| 10 |
10
InfuSystem Holdings
INFU
$270M
| $270M | $13.56 | 1.12% |
|
| 11 |
11
OraSure Technologies
OSUR
$269M
| $269M | $3.90 | 2.63% |
|
Small Cap Medical Instruments & Supplies Stocks at a Glance
Medical instruments and supplies companies make the consumables and tools of daily care — syringes, catheters, surgical instruments, dental equipment, and eyewear. Recurring, procedure-driven demand makes the group defensive, with razor-and-blade consumable models supporting stable margins.
There are 11 small cap Medical Instruments & Supplies stocks — companies in the Medical Instruments & Supplies industry with a market cap between $250M and $2B — worth a combined $9.92B.
The largest by market cap are LeMaitre Vascular (LMAT) at $1.85B, Dentsply Sirona (XRAY) at $1.76B and Azenta (AZTA) at $1.65B.
Among institutional investors, STAAR Surgical (STAA) drew the most net new fund positions in Q2 2026: 50 funds opened new positions, taking total fund holders up 14 (7.5%) quarter-over-quarter.
- Combined market cap: $9.92B across 11 stocks.
- Small Cap: market cap between $250M and $2B.
- Largest constituent: LeMaitre Vascular (LMAT), $1.85B market cap.
- Most net new fund positions in Q2 2026: STAAR Surgical (STAA), +14 holders.
Market caps and prices updated daily; fund activity based on aggregated SEC 13F filings for Q2 2026.